Valion Bio, Inc
Price
FilingsNewest: Form 8-K, director or officer changeNov 16 →Insiders2 insiders bought $28,450 in 2 open-market buys. No sales.→Financing →PeersClosest companies: KTTA, INDP, IMNN→
From the filings
Figures
- Revenue
- $462,000last 12 months
- Net income
- −$18.8Mlast 12 months
- Operating cash flow
- −$14.6Mlast 12 months
- Cash and equivalents
- $2.1Mat the last balance sheet
- Shares outstanding
- 4.2M shareson issue
Filings, newest first
- Nov 168-KDirector or officer change
- Nov 98-KMaterial agreement
- Nov 58-KDirector or officer change
- Nov 28-KDirector or officer change
- Oct 298-KOther events
- Oct 278-KMaterial agreement
- Oct 268-KOther events
- Oct 228-KOther events
- Sep 244Insider trade
- Sep 244Insider trade
- Mar 3010-KAnnual report